Overview

Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor

Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to see if treatment with intrahepatic chemotherapy is a good options in patients with liver metastases. If the patients have colorectal cancer and never had got chemotherapy the investigators will use oxaliplatin together with capecitabine. If the patient is K-RAS wild type the investigators will add cetuximab. In patients who had received oxaliplatin or in patients with other cancers the investigators will use mitomycin and gemcitabine together with capecitabine.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Copenhagen University Hospital at Herlev
Treatments:
Gemcitabine
Mitomycin
Mitomycins
Oxaliplatin
Criteria
Inclusion Criteria:

- liver metastasis

- solid tumor

Exclusion Criteria:

- poor performance